194 related articles for article (PubMed ID: 29696707)
1. Daily adjunctive therapy with vitamin D
Bekele A; Gebreselassie N; Ashenafi S; Kassa E; Aseffa G; Amogne W; Getachew M; Aseffa A; Worku A; Raqib R; Agerberth B; Hammar U; Bergman P; Aderaye G; Andersson J; Brighenti S
J Intern Med; 2018 Sep; 284(3):292-306. PubMed ID: 29696707
[TBL] [Abstract][Full Text] [Related]
2. Significant Effects of Oral Phenylbutyrate and Vitamin D3 Adjunctive Therapy in Pulmonary Tuberculosis: A Randomized Controlled Trial.
Mily A; Rekha RS; Kamal SM; Arifuzzaman AS; Rahim Z; Khan L; Haq MA; Zaman K; Bergman P; Brighenti S; Gudmundsson GH; Agerberth B; Raqib R
PLoS One; 2015; 10(9):e0138340. PubMed ID: 26394045
[TBL] [Abstract][Full Text] [Related]
3. Immune responses in the treatment of drug-sensitive pulmonary tuberculosis with phenylbutyrate and vitamin D
Rekha RS; Mily A; Sultana T; Haq A; Ahmed S; Mostafa Kamal SM; van Schadewijk A; Hiemstra PS; Gudmundsson GH; Agerberth B; Raqib R
BMC Infect Dis; 2018 Jul; 18(1):303. PubMed ID: 29973153
[TBL] [Abstract][Full Text] [Related]
4. High-dose vitamin D3 in adults with pulmonary tuberculosis: a double-blind randomized controlled trial.
Tukvadze N; Sanikidze E; Kipiani M; Hebbar G; Easley KA; Shenvi N; Kempker RR; Frediani JK; Mirtskhulava V; Alvarez JA; Lomtadze N; Vashakidze L; Hao L; Del Rio C; Tangpricha V; Blumberg HM; Ziegler TR
Am J Clin Nutr; 2015 Nov; 102(5):1059-69. PubMed ID: 26399865
[TBL] [Abstract][Full Text] [Related]
5. Daily Nutritional Supplementation with Vitamin D₃ and Phenylbutyrate to Treatment-Naïve HIV Patients Tested in a Randomized Placebo-Controlled Trial.
Ashenafi S; Amogne W; Kassa E; Gebreselassie N; Bekele A; Aseffa G; Getachew M; Aseffa A; Worku A; Hammar U; Bergman P; Aderaye G; Andersson J; Brighenti S
Nutrients; 2019 Jan; 11(1):. PubMed ID: 30634590
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of vitamin D
Sudfeld CR; Mugusi F; Aboud S; Nagu TJ; Wang M; Fawzi WW
Trials; 2017 Feb; 18(1):66. PubMed ID: 28183335
[TBL] [Abstract][Full Text] [Related]
7. High-Dose Vitamin D
Ganmaa D; Munkhzul B; Fawzi W; Spiegelman D; Willett WC; Bayasgalan P; Baasansuren E; Buyankhishig B; Oyun-Erdene S; Jolliffe DA; Xenakis T; Bromage S; Bloom BR; Martineau AR
Am J Respir Crit Care Med; 2017 Sep; 196(5):628-637. PubMed ID: 28692301
[TBL] [Abstract][Full Text] [Related]
8. High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial.
Martineau AR; Timms PM; Bothamley GH; Hanifa Y; Islam K; Claxton AP; Packe GE; Moore-Gillon JC; Darmalingam M; Davidson RN; Milburn HJ; Baker LV; Barker RD; Woodward NJ; Venton TR; Barnes KE; Mullett CJ; Coussens AK; Rutterford CM; Mein CA; Davies GR; Wilkinson RJ; Nikolayevskyy V; Drobniewski FA; Eldridge SM; Griffiths CJ
Lancet; 2011 Jan; 377(9761):242-50. PubMed ID: 21215445
[TBL] [Abstract][Full Text] [Related]
9. Homeopathic treatment in addition to standard care in multi drug resistant pulmonary tuberculosis: a randomized, double blind, placebo controlled clinical trial.
Chand KS; Manchanda RK; Mittal R; Batra S; Banavaliker JN; De I
Homeopathy; 2014 Apr; 103(2):97-107. PubMed ID: 24685414
[TBL] [Abstract][Full Text] [Related]
10. Adjunctive vitamin D for treatment of active tuberculosis in India: a randomised, double-blind, placebo-controlled trial.
Daley P; Jagannathan V; John KR; Sarojini J; Latha A; Vieth R; Suzana S; Jeyaseelan L; Christopher DJ; Smieja M; Mathai D
Lancet Infect Dis; 2015 May; 15(5):528-34. PubMed ID: 25863562
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial.
Wejse C; Gomes VF; Rabna P; Gustafson P; Aaby P; Lisse IM; Andersen PL; Glerup H; Sodemann M
Am J Respir Crit Care Med; 2009 May; 179(9):843-50. PubMed ID: 19179490
[TBL] [Abstract][Full Text] [Related]
12. Randomized trial of vitamin D3 to prevent worsening of musculoskeletal symptoms in women with breast cancer receiving adjuvant letrozole. The VITAL trial.
Khan QJ; Kimler BF; Reddy PS; Sharma P; Klemp JR; Nydegger JL; Yeh HW; Fabian CJ
Breast Cancer Res Treat; 2017 Nov; 166(2):491-500. PubMed ID: 28770449
[TBL] [Abstract][Full Text] [Related]
13. Adjunctive vitamin A and D during pulmonary tuberculosis treatment: a randomized controlled trial with a 2 × 2 factorial design.
Wang J; Xiong K; Wang Q; Zhao S; Liu Y; Ma A
Food Funct; 2020 May; 11(5):4672-4681. PubMed ID: 32406431
[TBL] [Abstract][Full Text] [Related]
14. L-arginine and vitamin D adjunctive therapies in pulmonary tuberculosis: a randomised, double-blind, placebo-controlled trial.
Ralph AP; Waramori G; Pontororing GJ; Kenangalem E; Wiguna A; Tjitra E; Sandjaja ; Lolong DB; Yeo TW; Chatfield MD; Soemanto RK; Bastian I; Lumb R; Maguire GP; Eisman J; Price RN; Morris PS; Kelly PM; Anstey NM
PLoS One; 2013; 8(8):e70032. PubMed ID: 23967066
[TBL] [Abstract][Full Text] [Related]
15. Prevention of relapse in drug sensitive pulmonary tuberculosis patients with and without vitamin D3 supplementation: A double blinded randomized control clinical trial.
Sinha S; Thukral H; Shareef I; Desai D; Singh BK; Das BK; Dhooria S; Sarin R; Singla R; Meena SK; Pandey RM; Pandey S; Sethi S; Kajal A; Yadav R; Aggarwal AN; Bhadada S; Behera D
PLoS One; 2023; 18(3):e0272682. PubMed ID: 36996065
[TBL] [Abstract][Full Text] [Related]
16. Arginine as an adjuvant to chemotherapy improves clinical outcome in active tuberculosis.
Schön T; Elias D; Moges F; Melese E; Tessema T; Stendahl O; Britton S; Sundqvist T
Eur Respir J; 2003 Mar; 21(3):483-8. PubMed ID: 12662006
[TBL] [Abstract][Full Text] [Related]
17. Oral intake of phenylbutyrate with or without vitamin D3 upregulates the cathelicidin LL-37 in human macrophages: a dose finding study for treatment of tuberculosis.
Mily A; Rekha RS; Kamal SM; Akhtar E; Sarker P; Rahim Z; Gudmundsson GH; Agerberth B; Raqib R
BMC Pulm Med; 2013 Apr; 13():23. PubMed ID: 23590701
[TBL] [Abstract][Full Text] [Related]
18. Short-term vitamin D3 supplementation lowers plasma renin activity in patients with stable chronic heart failure: an open-label, blinded end point, randomized prospective trial (VitD-CHF trial).
Schroten NF; Ruifrok WP; Kleijn L; Dokter MM; Silljé HH; Lambers Heerspink HJ; Bakker SJ; Kema IP; van Gilst WH; van Veldhuisen DJ; Hillege HL; de Boer RA
Am Heart J; 2013 Aug; 166(2):357-364.e2. PubMed ID: 23895820
[TBL] [Abstract][Full Text] [Related]
19. Effect of different dosages of oral vitamin D supplementation on vitamin D status in healthy, breastfed infants: a randomized trial.
Gallo S; Comeau K; Vanstone C; Agellon S; Sharma A; Jones G; L'Abbé M; Khamessan A; Rodd C; Weiler H
JAMA; 2013 May; 309(17):1785-92. PubMed ID: 23632722
[TBL] [Abstract][Full Text] [Related]
20. Phenylbutyrate Is Bacteriostatic against Mycobacterium tuberculosis and Regulates the Macrophage Response to Infection, Synergistically with 25-Hydroxy-Vitamin D3.
Coussens AK; Wilkinson RJ; Martineau AR
PLoS Pathog; 2015 Jul; 11(7):e1005007. PubMed ID: 26133770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
